## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: PEG 2.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($76.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Nomura Holdings Inc. Acquires 38,659 Shares of Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251216T105052 | Somewhat-Bullish | Relevance: 100%
- Nomura Holdings Inc. significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) during the second quarter, growing its holdings by 150.9% to 64,272 shares, valued at $5.84 million. Other institutional investors also adjusted their positions in CL, with 80.41% of the stock now owned by institutions. The article also details recent analyst ratings, price performance, earnings data, and a new quarterly dividend announcement for Colgate-Palmolive.

**2. Colgate-Palmolive Company $CL Shares Bought by Hudson Bay Capital Management LP**
- Source: MarketBeat | 20251215T105909 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP significantly increased its stake in Colgate-Palmolive Company by 4,211.6% in the second quarter, now holding 105,721 shares valued at approximately $9.61 million. Institutional investors collectively own about 80.41% of the stock. Colgate-Palmolive recently reported Q3 EPS of $0.91, beating estimates, and declared a quarterly dividend of $0.52.

**3. MASTERINVEST Kapitalanlage GmbH Acquires Shares of 28,070 Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251214T170809 | Somewhat-Bullish | Relevance: 100%
- MASTERINVEST Kapitalanlage GmbH has acquired a new stake of 28,070 shares in Colgate-Palmolive, valued at approximately $2.55 million in Q2. Other institutional investors also adjusted their holdings, with Vanguard Group Inc. holding the largest position. Colgate-Palmolive recently reported Q3 earnings of $0.91 EPS, beating estimates, and a quarterly revenue of $5.13 billion, slightly below expectations, while maintaining a "Moderate Buy" consensus rating from analysts with an $89.00 average price target.

**4. Public Sector Pension Investment Board Has $69.50 Million Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251214T105519 | Somewhat-Bullish | Relevance: 100%
- The Public Sector Pension Investment Board reduced its stake in Colgate-Palmolive Company by 6.0% during the second quarter, now holding 764,582 shares valued at $69.50 million. Despite this reduction, other institutional investors have increased their positions in the company. Colgate-Palmolive (NYSE:CL) reported strong earnings, exceeding analyst expectations, and declared a quarterly dividend of $0.52 per share.

**5. Colgate-Palmolive (CL): Reassessing Valuation After RBCâ€™s Upgrade to Outperform**
- Source: Simply Wall Street | 20251213T192243 | Somewhat-Bullish | Relevance: 100%
- RBC Capital has upgraded Colgate-Palmolive (CL) to an outperform rating, citing consistent organic growth and solid execution. Despite a recent tough stretch with negative year-to-date share price returns, the stock is trading at a double-digit discount to analyst targets, suggesting potential undervaluation. However, a market multiple analysis shows the company trading above its peers and industry, flashing a caution light on its current valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Argus Research | $0 | $0 | 0% |
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Argus Research | down | Hold |
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 7 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Long-term trend broken: trading 7.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +6.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.96 signals overvaluation risk, limited margin of safety. Forward P/E 20.7x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $64.2B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.96 |
| Forward P/E | 20.7 |
| Current P/E | 21.7 |
| YoY Growth | 5.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.8% to 3.8% (+6.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 71st percentile. MRS_5 at 3.5% confirms short-term momentum alignment. Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 54. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.78% (CS: 72) | Strong |
| RSI_14 | 54.5 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 0.924x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.43
- **Stop Loss:** $76.53 (3.7% risk)
- **Target:** $82.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 413
- **Position Value:** $32,804.59
- **Portfolio %:** 32.80%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*